CODX · Co-Diagnostics Inc
United States · RS rating 2 · As of 2026-11-03
| Price | 0.38 USD |
|---|---|
| 1-day change | +7.7% |
| RS rating (overall / 1M / 3M / 12M) | 2 / 2 / 3 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 29 / 2 / 50 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +64.0% |
| Sales growth Q/Q | +81.5% |
| Distance from 52-week high | +96.9% |
| Market cap (USD) | $6.2M |